Media stories about Healthequity (NASDAQ:HQY) have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Healthequity earned a coverage optimism score of 0.08 on Accern’s scale. Accern also assigned headlines about the company an impact score of 45.599628227574 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
These are some of the news headlines that may have impacted Accern Sentiment’s scoring:
Several equities analysts have recently issued reports on HQY shares. SunTrust Banks raised their price target on shares of Healthequity to $70.00 and gave the company a “buy” rating in a research note on Tuesday, March 20th. Oppenheimer raised their price target on shares of Healthequity from $58.00 to $68.00 and gave the company an “outperform” rating in a research note on Tuesday, March 20th. JPMorgan Chase dropped their price target on shares of Healthequity from $52.00 to $51.00 and set an “overweight” rating for the company in a research note on Wednesday, January 24th. Zacks Investment Research raised shares of Healthequity from a “hold” rating to a “buy” rating and set a $68.00 price target for the company in a research note on Tuesday, April 3rd. Finally, Barrington Research raised their price target on shares of Healthequity to $65.00 and gave the company an “outperform” rating in a research note on Tuesday, March 20th. Two investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. Healthequity presently has an average rating of “Buy” and a consensus target price of $66.50.
Shares of NASDAQ HQY opened at $65.32 on Friday. Healthequity has a twelve month low of $40.21 and a twelve month high of $68.75. The firm has a market cap of $4,034.42, a P/E ratio of 120.96, a PEG ratio of 2.65 and a beta of 1.39.
Healthequity (NASDAQ:HQY) last announced its earnings results on Monday, March 19th. The company reported $0.06 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.06. Healthequity had a net margin of 20.64% and a return on equity of 13.47%. The business had revenue of $60.44 million during the quarter, compared to the consensus estimate of $58.46 million. analysts expect that Healthequity will post 0.77 EPS for the current fiscal year.
In other Healthequity news, VP Darcy G. Mott sold 9,500 shares of Healthequity stock in a transaction on Monday, January 22nd. The shares were sold at an average price of $48.00, for a total value of $456,000.00. Following the completion of the sale, the vice president now directly owns 99,500 shares of the company’s stock, valued at $4,776,000. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, VP Ashley Dreier sold 12,000 shares of Healthequity stock in a transaction on Monday, January 29th. The shares were sold at an average price of $52.00, for a total transaction of $624,000.00. Following the completion of the sale, the vice president now directly owns 17,652 shares of the company’s stock, valued at $917,904. The disclosure for this sale can be found here. Insiders have sold 750,831 shares of company stock valued at $40,420,618 in the last three months. 29.00% of the stock is owned by insiders.
COPYRIGHT VIOLATION NOTICE: “Healthequity (HQY) Earning Somewhat Favorable Press Coverage, Report Finds” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2018/04/22/healthequity-hqy-earning-somewhat-favorable-press-coverage-report-finds.html.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.